This trial will test if opioid antagonists can help with idiopathic hypogonadotropic hypogonadism by looking at the subject's hypothalamic-pituitary-gonadal axis.
1 Primary · 1 Secondary · Reporting Duration: 35 hours
Experimental Treatment
23 Total Participants · 1 Treatment Group
Primary Treatment: kisspeptin, GnRH, naloxone · No Placebo Group · Phase 2
Age 18 - 75 · All Participants · 10 Total Inclusion Criteria
Mark “Yes” if the following statements are true for you: